QuidelOrtho (QDEL)

NASDAQHealth CareMedical - SpecialtiesSnapshot 2026-09-04

$13.97+0.29%

Close 2026-09-04 · 1-day change

QuarterlyIQ Insights · QDEL

Financials

Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.

Income Statement

Period

View

Order

Figures in millions of USD, except per-share and ratios.

	TTM	FY 2026	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenues
Revenues	—	2,730.2	2,730.2	2,782.9	3,266.0	1,698.6	1,661.7
Total Revenues	—	2,730.2	2,730.2	2,782.9	3,266.0	1,698.6	1,661.7
Operating Expenses & Income
Selling, General & Admin	—	746.3	746.3	766.8	621.0	239.6	180.7
R&D Expenses	—	186.2	186.2	218.7	187.9	95.7	84.3
Operating Income	—	(919.2)	(919.2)	(1,960.9)	843.7	906.0	1,060.3
Earnings from Continuing Operations
Interest Expense	—	—	177.6	163.5	—	—	—
EBT, Incl. Unusual Items	—	(1,107.7)	(1,107.7)	(2,131.5)	735.9	900.3	1,040.3
Income Tax Expense	—	24.1	24.1	(79.5)	187.2	196.1	230.0
Net Income
Net Income	—	(1,131.8)	(1,131.8)	(2,052.0)	548.7	704.2	810.3
Per Share
Basic EPS	—	(16.69)	(16.69)	(30.54)	9.66	16.74	19.24
Diluted EPS	—	(16.69)	(16.69)	(30.54)	9.56	16.43	18.60
Basic Weighted Avg Shares	68.3	67.8	67.8	67.2	56.8	42.1	42.1
Diluted Weighted Avg Shares	68.3	67.8	67.8	67.2	57.4	42.9	43.6
Supplemental
EBITDA	—	(666.4)	(666.4)	(1,710.9)	994.8	930.3	1,081.1
EBIT	—	(919.2)	(919.2)	(1,960.9)	843.7	906.0	1,060.3
Effective Tax Rate	—	-2.2%	—	—	25.4%	21.8%	22.1%

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.